▶ 調査レポート

急性虚血性脳卒中薬のグローバル市場：規模・現状・予測2019-2025
• 英文タイトル：Global Acute Ischemic Stroke Drugs Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。急性虚血性脳卒中薬のグローバル市場：規模・現状・予測2019-2025 / Global Acute Ischemic Stroke Drugs Market Size, Status and Forecast 2019-2025 / QYR9NV17591資料のイメージです。• レポートコード：QYR9NV17591
• 出版社/出版日：QYResearch / 2019年11月18日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、90ページ
• 納品方法：Eメール（受注後2-3営業日）
• 産業分類：医薬品・ヘルスケア
• 販売価格（消費税別）
  Single User￥577,200 (USD3,900)▷ お問い合わせ
  Enterprise License￥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
※当調査レポートでは、急性虚血性脳卒中薬の世界市場について調査・分析し、急性虚血性脳卒中薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（タブレット、カプセル、その他）、用途別（病院、診断センター、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。


・レポートの概要
・世界の急性虚血性脳卒中薬市場動向
・主要企業別マーケットシェア
・急性虚血性脳卒中薬の種類別市場規模2014-2019
（タブレット、カプセル、その他）
・急性虚血性脳卒中薬の用途別市場規模2014-2019
（病院、診断センター、その他）
・急性虚血性脳卒中薬の北米市場：主要企業・種類別/用途別市場規模
・急性虚血性脳卒中薬のヨーロッパ市場：主要企業・種類別/用途別市場規模
・急性虚血性脳卒中薬の中国市場：主要企業・種類別/用途別市場規模
・急性虚血性脳卒中薬の日本国内市場：主要企業・種類別/用途別市場規模
・急性虚血性脳卒中薬の東南アジア市場：主要企業・種類別/用途別市場規模
・急性虚血性脳卒中薬のインド市場：主要企業・種類別/用途別市場規模
・急性虚血性脳卒中薬の中南米市場：主要企業・種類別/用途別市場規模
・主要企業のプロフィール
（Sanofi、Biogen、Bayer、Pfizer、Roche、Boehringer Ingelheim、Daiichi Sankyo、Bristol-Myers Squibb、Johnson＆Johnson、AstraZeneca、ZZ Biotech、NoNO Inc、Athersys、SanBio）
・急性虚血性脳卒中薬の市場規模予測2019-2025
（種類別、用途別、地域別市場予測）
・アナリストの観点・結論
...

Acute Ischemic Stroke (CIS), also known as Cerebral Infarction (CI), is due to the occlusion of the Cerebral artery caused by the Infarction of brain tissue, accompanied by damage to neurons, astrocytes, oligodendrocytes, is the modern society leading to death and disability of the most important central nervous system vascular events.In 2018, the global Acute Ischemic Stroke Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Acute Ischemic Stroke Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Acute Ischemic Stroke Drugs development in North America, Europe, China and Japan.

The key players covered in this study
Sanofi
Biogen
Bayer
Pfizer
Roche
Boehringer Ingelheim
Daiichi Sankyo
Bristol-Myers Squibb
Johnson＆Johnson
AstraZeneca
ZZ Biotech
NoNO Inc
Athersys
SanBio

Market segment by Type, the product can be split into
Tablet
Capsule
Other

Market segment by Application, split into
Hospitals
Diagnostic Centers
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan

The study objectives of this report are:
To analyze global Acute Ischemic Stroke Drugs status, future forecast, growth opportunity, key market and key players.
To present the Acute Ischemic Stroke Drugs development in North America, Europe, China and Japan.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Acute Ischemic Stroke Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Acute Ischemic Stroke Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Tablet
1.4.3 Capsule
1.4.4 Other
1.5 Market by Application
1.5.1 Global Acute Ischemic Stroke Drugs Market Share by Application (2019-2025)
1.5.2 Hospitals
1.5.3 Diagnostic Centers
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Acute Ischemic Stroke Drugs Market Size
2.2 Acute Ischemic Stroke Drugs Growth Trends by Regions
2.2.1 Acute Ischemic Stroke Drugs Market Size by Regions (2019-2025)
2.2.2 Acute Ischemic Stroke Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Acute Ischemic Stroke Drugs Market Size by by Players
3.1.1 Global Acute Ischemic Stroke Drugs Revenue by by Players (2014-2019)
3.1.2 Global Acute Ischemic Stroke Drugs Revenue Market Share by by Players (2014-2019)
3.1.3 Global Acute Ischemic Stroke Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Acute Ischemic Stroke Drugs Key Players Head office and Area Served
3.3 Key Players Acute Ischemic Stroke Drugs Product/Solution/Service
3.4 Date of Enter into Acute Ischemic Stroke Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Acute Ischemic Stroke Drugs Market Size by Type (2014-2019)
4.2 Global Acute Ischemic Stroke Drugs Market Size by Application (2014-2019)

5 North America
5.1 North America Acute Ischemic Stroke Drugs Market Size (2014-2019)
5.2 Acute Ischemic Stroke Drugs Key Players in North America
5.3 North America Acute Ischemic Stroke Drugs Market Size by Type
5.4 North America Acute Ischemic Stroke Drugs Market Size by Application

6 Europe
6.1 Europe Acute Ischemic Stroke Drugs Market Size (2014-2019)
6.2 Acute Ischemic Stroke Drugs Key Players in Europe
6.3 Europe Acute Ischemic Stroke Drugs Market Size by Type
6.4 Europe Acute Ischemic Stroke Drugs Market Size by Application

7 China
7.1 China Acute Ischemic Stroke Drugs Market Size (2014-2019)
7.2 Acute Ischemic Stroke Drugs Key Players in China
7.3 China Acute Ischemic Stroke Drugs Market Size by Type
7.4 China Acute Ischemic Stroke Drugs Market Size by Application

8 Japan
8.1 Japan Acute Ischemic Stroke Drugs Market Size (2014-2019)
8.2 Acute Ischemic Stroke Drugs Key Players in Japan
8.3 Japan Acute Ischemic Stroke Drugs Market Size by Type
8.4 Japan Acute Ischemic Stroke Drugs Market Size by Application

9 International Players Profiles
9.1 Sanofi
9.1.1 Sanofi Company Details
9.1.2 Company Description and Business Overview
9.1.3 Acute Ischemic Stroke Drugs Introduction
9.1.4 Sanofi Revenue in Acute Ischemic Stroke Drugs Business (2014-2019))
9.1.5 Sanofi Recent Development
9.2 Biogen
9.2.1 Biogen Company Details
9.2.2 Company Description and Business Overview
9.2.3 Acute Ischemic Stroke Drugs Introduction
9.2.4 Biogen Revenue in Acute Ischemic Stroke Drugs Business (2014-2019)
9.2.5 Biogen Recent Development
9.3 Bayer
9.3.1 Bayer Company Details
9.3.2 Company Description and Business Overview
9.3.3 Acute Ischemic Stroke Drugs Introduction
9.3.4 Bayer Revenue in Acute Ischemic Stroke Drugs Business (2014-2019)
9.3.5 Bayer Recent Development
9.4 Pfizer
9.4.1 Pfizer Company Details
9.4.2 Company Description and Business Overview
9.4.3 Acute Ischemic Stroke Drugs Introduction
9.4.4 Pfizer Revenue in Acute Ischemic Stroke Drugs Business (2014-2019)
9.4.5 Pfizer Recent Development
9.5 Roche
9.5.1 Roche Company Details
9.5.2 Company Description and Business Overview
9.5.3 Acute Ischemic Stroke Drugs Introduction
9.5.4 Roche Revenue in Acute Ischemic Stroke Drugs Business (2014-2019)
9.5.5 Roche Recent Development
9.6 Boehringer Ingelheim
9.6.1 Boehringer Ingelheim Company Details
9.6.2 Company Description and Business Overview
9.6.3 Acute Ischemic Stroke Drugs Introduction
9.6.4 Boehringer Ingelheim Revenue in Acute Ischemic Stroke Drugs Business (2014-2019)
9.6.5 Boehringer Ingelheim Recent Development
9.7 Daiichi Sankyo
9.7.1 Daiichi Sankyo Company Details
9.7.2 Company Description and Business Overview
9.7.3 Acute Ischemic Stroke Drugs Introduction
9.7.4 Daiichi Sankyo Revenue in Acute Ischemic Stroke Drugs Business (2014-2019)
9.7.5 Daiichi Sankyo Recent Development
9.8 Bristol-Myers Squibb
9.8.1 Bristol-Myers Squibb Company Details
9.8.2 Company Description and Business Overview
9.8.3 Acute Ischemic Stroke Drugs Introduction
9.8.4 Bristol-Myers Squibb Revenue in Acute Ischemic Stroke Drugs Business (2014-2019)
9.8.5 Bristol-Myers Squibb Recent Development
9.9 Johnson＆Johnson
9.9.1 Johnson＆Johnson Company Details
9.9.2 Company Description and Business Overview
9.9.3 Acute Ischemic Stroke Drugs Introduction
9.9.4 Johnson＆Johnson Revenue in Acute Ischemic Stroke Drugs Business (2014-2019)
9.9.5 Johnson＆Johnson Recent Development
9.10 AstraZeneca
9.10.1 AstraZeneca Company Details
9.10.2 Company Description and Business Overview
9.10.3 Acute Ischemic Stroke Drugs Introduction
9.10.4 AstraZeneca Revenue in Acute Ischemic Stroke Drugs Business (2014-2019)
9.10.5 AstraZeneca Recent Development
9.11 ZZ Biotech
9.12 NoNO Inc
9.13 Athersys
9.14 SanBio

10 Market Forecast 2019-2025
10.1 Market Size Forecast by Product (2019-2025)
10.2 Market Size Forecast by Application (2019-2025)
10.3 Market Size Forecast by Regions
10.4 North America
10.5 Europe
10.6 China
10.7 Japan

11 Analyst’s Viewpoints/Conclusions

12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Disclaimer
12.3 Author Details

List of Tables and Figures

Table Acute Ischemic Stroke Drugs Key Market Segments
Table Key Players Acute Ischemic Stroke Drugs Covered
Table Global Acute Ischemic Stroke Drugs Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Tablet Figures
Table Key Players of Tablet
Figuer Capsule Figures
Table Key Players of Capsule
Figuer Other Figures
Table Key Players of Other
Table Global Acute Ischemic Stroke Drugs Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Acute Ischemic Stroke Drugs Market Share by Application in 2018 & 2025
Figure Hospitals Case Studies
Figure Diagnostic Centers Case Studies
Figure Others Case Studies
Figure Acute Ischemic Stroke Drugs Report Years Considered
Figure Global Acute Ischemic Stroke Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Acute Ischemic Stroke Drugs Market Size by Regions 2019-2025 (Million US$)
Table Global Acute Ischemic Stroke Drugs Market Size by Regions 2019-2025 (Million US$)
Table Global Acute Ischemic Stroke Drugs Market Share by Regions 2014-2019
Figure Global Acute Ischemic Stroke Drugs Market Share by Regions 2014-2019
Figure Global Acute Ischemic Stroke Drugs Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Acute Ischemic Stroke Drugs Revenue by by Players (2014-2019) (Million US$)
Table Global Acute Ischemic Stroke Drugs Market Share by by Players (2014-2019)
Figure Global Acute Ischemic Stroke Drugs Market Share by by Players in 2018
Table Global Acute Ischemic Stroke Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Acute Ischemic Stroke Drugs Product/Solution/Service
Table Date of Enter into Acute Ischemic Stroke Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Acute Ischemic Stroke Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Acute Ischemic Stroke Drugs Market Size Share by Type (2014-2019)
Figure Global Acute Ischemic Stroke Drugs Market Size Market Share by Type (2014-2019)
Table Global Acute Ischemic Stroke Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Acute Ischemic Stroke Drugs Market Size Share by Application (2014-2019)
Figure Global Acute Ischemic Stroke Drugs Market Size Market Share by Application (2014-2019)
Figure Global Acute Ischemic Stroke Drugs Revenue Market Share by Application in 2018
Figure North America Acute Ischemic Stroke Drugs Market Size 2014-2019 (Million US$)
Table North America Key Players Acute Ischemic Stroke Drugs Revenue (2018-2019) (Million US$)
Table North America Key Players Acute Ischemic Stroke Drugs Market Share (2018-2019)
Table North America Acute Ischemic Stroke Drugs Market Size by Type 2014-2019 (Million US$)
Table North America Acute Ischemic Stroke Drugs Market Share by Type 2014-2019
Table North America Acute Ischemic Stroke Drugs Market Size by Application 2014-2019 (Million US$)
Table North America Acute Ischemic Stroke Drugs Market Share by Application 2014-2019
Figure Europe Acute Ischemic Stroke Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Acute Ischemic Stroke Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Acute Ischemic Stroke Drugs Market Share (2018-2019)
Table Europe Acute Ischemic Stroke Drugs Market Size by Type 2014-2019 (Million US$)
Table Europe Acute Ischemic Stroke Drugs Market Share by Type 2014-2019
Table Europe Acute Ischemic Stroke Drugs Market Size by Application 2014-2019 (Million US$)
Table Europe Acute Ischemic Stroke Drugs Market Share by Application 2014-2019
Figure China Acute Ischemic Stroke Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Acute Ischemic Stroke Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Acute Ischemic Stroke Drugs Market Share (2018-2019)
Table China Acute Ischemic Stroke Drugs Market Size by Type 2014-2019 (Million US$)
Table China Acute Ischemic Stroke Drugs Market Share by Type 2014-2019
Table China Acute Ischemic Stroke Drugs Market Size by Application 2014-2019 (Million US$)
Table China Acute Ischemic Stroke Drugs Market Share by Application 2014-2019
Figure Japan Acute Ischemic Stroke Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Acute Ischemic Stroke Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Acute Ischemic Stroke Drugs Market Share (2018-2019)
Table Japan Acute Ischemic Stroke Drugs Market Size by Type 2014-2019 (Million US$)
Table Japan Acute Ischemic Stroke Drugs Market Share by Type 2014-2019
Table Japan Acute Ischemic Stroke Drugs Market Size by Application 2014-2019 (Million US$)
Table Japan Acute Ischemic Stroke Drugs Market Share by Application 2014-2019
Table Sanofi Company Details
Table Sanofi Revenue in Acute Ischemic Stroke Drugs Business 2014-2019 (Million US$)
Figure Sanofi Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2014-2019)
Table Sanofi Recent Development
Table Biogen Company Details
Table Biogen Revenue in Acute Ischemic Stroke Drugs Business 2014-2019 (Million US$)
Figure Biogen Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2014-2019)
Table Biogen Recent Development
Table Bayer Company Details
Table Bayer Revenue in Acute Ischemic Stroke Drugs Business 2014-2019 (Million US$)
Figure Bayer Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2014-2019)
Table Bayer Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Acute Ischemic Stroke Drugs Business 2014-2019 (Million US$)
Figure Pfizer Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2014-2019)
Table Pfizer Recent Development
Table Roche Company Details
Table Roche Revenue in Acute Ischemic Stroke Drugs Business 2014-2019 (Million US$)
Figure Roche Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2014-2019)
Table Roche Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Revenue in Acute Ischemic Stroke Drugs Business 2014-2019 (Million US$)
Figure Boehringer Ingelheim Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2014-2019)
Table Boehringer Ingelheim Recent Development
Table Daiichi Sankyo Company Details
Table Daiichi Sankyo Revenue in Acute Ischemic Stroke Drugs Business 2014-2019 (Million US$)
Figure Daiichi Sankyo Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2014-2019)
Table Daiichi Sankyo Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Acute Ischemic Stroke Drugs Business 2014-2019 (Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Johnson＆Johnson Company Details
Table Johnson＆Johnson Revenue in Acute Ischemic Stroke Drugs Business 2014-2019 (Million US$)
Figure Johnson＆Johnson Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2014-2019)
Table Johnson＆Johnson Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Acute Ischemic Stroke Drugs Business 2014-2019 (Million US$)
Figure AstraZeneca Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2014-2019)
Table AstraZeneca Recent Development
Table ZZ Biotech Company Details
Table NoNO Inc Company Details
Table Athersys Company Details
Table SanBio Company Details
Table Global Acute Ischemic Stroke Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Acute Ischemic Stroke Drugs Market Size Share by Regions (2019-2025)
Figure Global Acute Ischemic Stroke Drugs Market Size Share by Regions in 2025
Figure North America Acute Ischemic Stroke Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Acute Ischemic Stroke Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Acute Ischemic Stroke Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Acute Ischemic Stroke Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Acute Ischemic Stroke Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Acute Ischemic Stroke Drugs Market Size by Product (2019-2025)
Figure Global Acute Ischemic Stroke Drugs Market Size by Product in 2025
Table Global Acute Ischemic Stroke Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Acute Ischemic Stroke Drugs Market Size by Application (2019-2025)
Figure Global Acute Ischemic Stroke Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介
  • 急性虚血性脳卒中薬のグローバル市場：規模・現状・予測2019-2025
    Global Acute Ischemic Stroke Drugs Market Size, Status and Forecast 2019-2025
    QYR9NV17591 2019年11月18日 90Pages
    ※当調査レポートでは、急性虚血性脳卒中薬の世界市場について調査・分析し、急性虚血性脳卒中薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（タブレット、カプセル、その他）、用途別（病院、診断センター、...
  • 急性不穏＆攻撃症治療のグローバル市場：規模・現状・予測2019-2025
    Global Acute Agitation and Aggression Treatment Market Size, Status and Forecast 2019-2025
    QYR9NV17590 2019年11月18日 93Pages
    ※当調査レポートでは、急性不穏＆攻撃症治療の世界市場について調査・分析し、急性不穏＆攻撃症治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（経口、筋肉内注射、その他）、用途別（病院＆外来手術センタ...
  • 急性不穏＆攻撃症治療のグローバル市場：規模・現状・予測2019-2025
    Global Acute Agitation and Aggression Treatment Market Size, Status and Forecast 2019-2025
    QYR9NV17590 2019年11月18日 93Pages
    ※当調査レポートでは、急性不穏＆攻撃症治療の世界市場について調査・分析し、急性不穏＆攻撃症治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（経口、筋肉内注射、その他）、用途別（病院＆外来手術センタ...
  • 血栓溶解療法のグローバル市場：規模・現状・予測2019-2025
    Global Thrombolytic Therapy Market Size, Status and Forecast 2019-2025
    QYR9NV18487 2019年11月18日 93Pages
    ※当調査レポートでは、血栓溶解療法の世界市場について調査・分析し、血栓溶解療法の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（薬物治療、外科治療、その他の治療）、用途別（急性心筋梗塞、肺塞栓症、深部...
  • 血栓溶解療法のグローバル市場：規模・現状・予測2019-2025
    Global Thrombolytic Therapy Market Size, Status and Forecast 2019-2025
    QYR9NV18487 2019年11月18日 93Pages
    ※当調査レポートでは、血栓溶解療法の世界市場について調査・分析し、血栓溶解療法の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（薬物治療、外科治療、その他の治療）、用途別（急性心筋梗塞、肺塞栓症、深部...
  • そう痒治療薬のグローバル市場：規模・現状・予測2019-2025
    Global Pruritus Drugs Market Size, Status and Forecast 2019-2025
    QYR9NV18331 2019年11月18日 93Pages
    ※当調査レポートでは、そう痒治療薬の世界市場について調査・分析し、そう痒治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（局所、経口、非経口）、用途別（血液性そう痒症、腫瘍性そう痒症、腎そう痒症...
  • そう痒治療薬のグローバル市場：規模・現状・予測2019-2025
    Global Pruritus Drugs Market Size, Status and Forecast 2019-2025
    QYR9NV18331 2019年11月18日 93Pages
    ※当調査レポートでは、そう痒治療薬の世界市場について調査・分析し、そう痒治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（局所、経口、非経口）、用途別（血液性そう痒症、腫瘍性そう痒症、腎そう痒症...
  • 気管支拡張薬のグローバル市場：規模・現状・予測2019-2025
    Global Bronchiectasis Drugs Market Size, Status and Forecast 2019-2025
    QYR9NV17708 2019年11月18日 91Pages
    ※当調査レポートでは、気管支拡張薬の世界市場について調査・分析し、気管支拡張薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（抗生物質、去痰薬、その他の薬物）、用途別（病院、研究所、クリニック、その...
  • 起立性低血圧治療薬のグローバル市場：規模・現状・予測2019-2025
    Global Orthostatic Hypotension Drugs Market Size, Status and Forecast 2019-2025
    QYR9NV18245 2019年11月18日 90Pages
    ※当調査レポートでは、起立性低血圧治療薬の世界市場について調査・分析し、起立性低血圧治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（ミドドリン、ノーテラ（ドロキシドパ）、フルドロコルチゾン、そ...